Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-effect study of nalbuphine + ropivacaine for epidural labor analgesia
ChiCTR1900021268Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Obstetrics and Gynecology Hospital of Fudan University
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of nalbuphine and ropivacaine in labor pain, sponsored by Department of Anesthesiology, Obstetrics and Gynecology Hospital of Fudan University. Primary endpoint: EC90. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
nalbuphineropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR1900021268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021268.